Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Raised to $400 at SunTrust

February 7, 2020 6:24 AM
SunTrust analyst Robyn Karnauskas raised the price target on Regeneron Pharma (NASDAQ: REGN) to $400.00 (from $360.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles